Susan E. Turner

Inhibitors of protein kinase C. 1. 2,3-bisarylmaleimides

Peter D. Davis, Christopher H. Hill, Geoffrey Lawton et al. · Journal of Medicinal Chemistry · 1992 · 161 citations · Full text

Pharmacy, Chemistry, Pharmacology +12

Cell-Penetrating Pepducin Therapy Targeting PAR1 in Subjects With Coronary Artery Disease

Paul A. Gurbel, Kevin P. Bliden, Susan E. Turner et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2015 · 104 citations · Full text

Medicine, Cardiology, Pharmacology +16

Noncanonical Matrix Metalloprotease 1–Protease-Activated Receptor 1 Signaling Drives Progression of Atherosclerosis

Rajashree Rana, Tianfang Huang, Elizabeth K. Fletcher et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2018 · 50 citations · Full text

Medicine, Cardiology, Pharmacology +14

PAR1 (Protease-Activated Receptor 1) Pepducin Therapy Targeting Myocardial Necrosis in Coronary Artery Disease and Acute Coronary Syndrome Patients Undergoing Cardiac Catheterization

Athan Kuliopulos, Paul A. Gurbel, Jeffrey J. Rade et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2020 · 37 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Deficiency of MMP1a (Matrix Metalloprotease 1a) Collagenase Suppresses Development of Atherosclerosis in Mice

Elizabeth K. Fletcher, Yanling Wang, Laura K. Flynn et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2021 · 15 citations · Full text

Veterinary Medicine, Cardiology, Pathobiology +14